Group 2 demonstrated a significant reduction in hemoglobin A1c (HbA1c) by 1.90% (p = 0.004), along with a decrease in fasting blood glucose (FBG) by 3.6% (p = 0.009), body insulin by 8.6% (p = 0.009), and the homeostatic model assessment for insulin resistance (HOMA-IR) by 11.11% (p = 0.001). Here, INS is linked to Insulin resistance.